Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

Roche resubmits NDA for Xenical

Nov. 17, 1997

New guidelines for patients exposed to fenfluramine or dexfenfluramine

Nov. 17, 1997

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

Nov. 17, 1997

Novo Nordisk files for HRT product in U.S.

Nov. 13, 1997

Alendronate and etidronate prevent steroid-induced osteoporosis

Nov. 13, 1997

ACAT inhibitors described by Sankyo in patent literature

Nov. 13, 1997

Palatin obtains rights to new ED diagnostic/therapeutic

Nov. 12, 1997

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears new indication for Zocor

Nov. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...